Global Health Ltd. IPO

One of the largest private multi-speciality tertiary care providers operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. It operated under brand name "Medanta".

RHP
View
DRHP
View
Open Date

2022-11-03

Close Date

2022-11-07

Global Health Ltd. IPO Details

Check out the issue details for Global Health Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 336

Price Band

₹ 319 - 336

Issue Size

2205.57 Cr.

Issue Type

Book Built

Open

2022-11-03

Close

2022-11-07

Listingprice

₹ 401

ListingGain

19.35%

Listing Date

2022-11-16

CMP

₹ 1098.6

Current Return

226.96%

Global Health Ltd. News

Global Health informs about notice of postal ballot26 Nov, 4:58PM Global Health informs about notice of postal ballot 26 Nov, 4:41PM Global Health - Quaterly Results14 Nov, 1:37PM Global Health - Quaterly Results14 Nov, 1:37PM Global Health - Quaterly Results14 Nov, 1:37PM Global Health informs about board meeting7 Nov, 5:30PM Global Health informs about board meeting outcome 6 Nov, 5:53PM Global Health gets nod to sign agreement to operate 750 bedded hospital in New Delhi6 Nov, 4:13PM Global Health informs about investor meet16 Sep, 3:37PM Global Health informs about news clarification27 Aug, 9:46AM Global Health informs about analyst meet 26 Aug, 3:15PM Global Health - Quaterly Results8 Aug, 4:16PM Global Health - Quaterly Results8 Aug, 4:16PM Global Health - Quaterly Results8 Aug, 4:16PM Global Health informs about disclosure23 Jul, 3:25PM Global Health informs about clarification on news17 Jul, 2:13PM Global Health submits analyst meet intimation25 Jun, 4:21PM Global Health informs about investor presentation18 May, 11:32AM Global Health - Quaterly Results17 May, 4:07PM Global Health - Quaterly Results17 May, 4:07PM

Company Financials

You can get the following financial statements of Global Health Ltd. as of now.

Company Name

Global Health Ltd.

Exchange

NSE: MEDANTA BSE: 543654

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The details about the Global Health Ltd IPO is as:

  • The issue size of the IPO is 2205.57 Cr.
  • The price band for Global Health Ltd IPO is Rs 319 to Rs 336.
  • The shares of Global Health Ltd IPO will list on 16th November 2022.
  • The latest tentative GMP of Global Health Ltd IPO is Rs 20.
  • The shares of Global Health Ltd IPO is subscribed 9.58 Times as of 7th November 2022.

Global Health Ltd IPO Valuation

The approx valuation of Global Health Ltd IPO based on its price band and RHP/DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 336
Existing Shares (Qty) 25.33 Cr
Fresh Issue (Amount) 500 Cr
Market Cap 9010.88 Cr
EPS  Rs 7.78
PE Ratio 43.18x
Industry PE 51.93x

 

Global Health Ltd IPO Issue Size

Global Health Ltd IPO issue size is 2205.57 Cr.

Issue Amount
Fresh Issue 500 Cr
Offer For Sale 1705.57 Cr

 

Global Health Ltd IPO Market Lot

An Individual can apply for a minimum 1 lot of 44 shares and a maximum of 13 lots of 572 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 44 Rs 14,784
 Maximum 13 572 Rs 1,92,192

 

Global Health Ltd IPO Offer

The shares of Global Health Ltd IPO is subscribed 9.58 Times as of 7th November 2022. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 28.64 Times 
Non-Institutional Minimum 15% 4.02 Times
Retail Individual Minimum 35% 0.88 Times
Total   9.58 Times

 

Global Health Ltd IPO Grey Market Premium

As on GMP (Tentative)
10 November 2022 Rs 20
11 November 2022 Rs 20
12 November 2022 Rs 20
14 November 2022 Rs 20
15 November 2022 Rs 20

It is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

 

Find below the dates for Global health Ltd IPO:

Schedule Date
Basis of Allotment 11 Nov 2022
Refunds 14 Nov 2022
Credit to Demat Account 15 Nov 2022
IPO Listing Date 16 Nov 2022

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1472.09 1227.4 1764.96 1973.54 2280.01
Total Expenditure 1253.59 1054.48 1384.17 1551.52 1776.66
Operating Profit 218.5 172.91 380.79 422.02 503.35
Other Income 43.54 28.35 35.04 47.59 102.87
Interest 32.54 29.2 32.83 31.82 30.46
Depreciation 98.57 87.64 87.17 86.09 87.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 130.93 84.42 295.83 351.71 488.67
Provision for Tax 28.18 27.14 77.04 88.46 127.78
Net Profit 102.76 57.29 218.78 263.25 360.89
Adjusted EPS (Rs.) 0.42 0.23 0.86 0.98 1.34

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 81.85 82.09 50.64 53.64 53.7
Total Reserves 1340.88 1401.55 1689.11 2435.22 2795.1
Borrowings 18.08 19.35 88.72 57.98 0
Other N/C liabilities 306.37 646.92 723.17 810.9 958.08
Current liabilities 260.45 268.2 301.92 396.64 419.59
Total Liabilities 2007.62 2418.1 2853.57 3754.39 4226.47
Assets
Net Block 928.87 851.4 826.95 809.9 841.21
Capital WIP 3.47 4.16 6.42 74.94 183.31
Intangible WIP 0 0 0 0 0.78
Investments 500.5 625.55 734.02 764.99 790.1
Loans & Advances 121.6 470.38 562.48 680.41 1109.32
Other N/C Assets 17.41 11.32 7.59 26.24 11.2
Current Assets 435.77 455.29 716.12 1397.92 1290.55
Total Assets 2007.62 2418.1 2853.57 3754.39 4226.47
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Other Income 20.37 25.83 32.55 26.7 23.58
Profit Before Tax 126.89 120.87 125.17 129.74 143.61
Tax 31.8 33.53 32.93 33.46 39.14
Profit After Tax 95.1 87.35 92.24 96.28 104.47
Adjusted EPS (Rs) 3.54 3.25 3.44 3.59 3.89

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 33.04 0
Jun 2024 33.04 0
Mar 2024 33.04 0
Dec 2023 33.05 0
Sep 2023 33.06 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 130.93 84.42 295.83 351.71 488.67
Adjustment 121.74 104.94 99.85 83.3 53.02
Changes in Assets & Liabilities -3.95 26.16 -69.49 96.47 -56.37
Tax Paid -56.16 -14.63 -90.78 -100.95 -144.69
Operating Cash Flow 192.56 200.88 235.4 430.53 340.64
Investing Cash Flow -45.34 -250.46 -312.99 -257.29 -698.53
Financing Cash Flow -55.64 -36.67 97.59 404.22 -66.23
Net Cash Flow 91.58 -86.25 20.01 577.47 -424.11
X